Chinese mRNA vaccine outperforms protein jab against hydatid disease in lambs
Researchers in China have developed an mRNA vaccine targeting the EG95 antigen that gave stronger and longer-lasting protection against cystic echinococcosis than a commercial protein vaccine in mice and lambs. The results point to a scalable new tool for controlling the tapeworm-borne disease, which passes between livestock, dogs and humans.
A Chinese research team has reported that mRNA vaccines targeting the EG95 antigen can generate stronger and longer-lasting protection against cystic echinococcosis than the established protein-subunit approach. The finding matters because the disease, caused by the tapeworm Echinococcus granulosus, still imposes a heavy burden in livestock systems where dogs and grazing animals live in close proximity to people.
In work published in PLOS Pathogens, the scientists compared three lipid-nanoparticle vaccines in mice and lambs: a standard EG95 construct, a fusion of EG95 with interleukin-4, and a multivalent version carrying antigens from Echinococcus canadensis. All three produced robust expression and outperformed a commercial EG95 subunit vaccine, but the IL-4-EG95 formulation delivered the most striking protection after challenge.
The mRNA candidates generated stronger antibody and T-cell responses, and those antibodies persisted for more than 12 months. That durability is a practical advantage in endemic rural areas, where repeated boosting is difficult and costly.
Cystic echinococcosis often remains silent for years before hydatid cysts damage the liver or lungs, and treatment may require surgery or prolonged drug therapy, according to the US Centres for Disease Control and Prevention. The World Health Organization says control depends on sanitation, education and, in some settings, mass drug administration.
The study suggests that veterinary mRNA vaccines could become a more scalable tool for one of the most stubborn neglected zoonoses.
"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."